<div id="readability-page-1"><p>H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Quantum-Si today and set a price target of $4.00.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>Ramakanth covers the Healthcare sector, focusing on stocks such as Corcept Therapeutics, Evaxion Biotech, and Delcath Systems. According to TipRanks, Ramakanth has an average return of <span>22.5%</span> and a 45.11% success rate on recommended stocks. </p> <p>In addition to H.C. Wainwright, Quantum-Si also received a Buy from Alliance Global Partners’s Scott Henry in a report issued on November 7. However, on November 6, TR | OpenAI – 4o reiterated a Hold rating on Quantum-Si (NASDAQ: QSI).</p></div>

<p>H.C. Wainwright analyst Swayampakula Ramakanth has reiterated a Buy rating on Quantum-Si (QSI) with a price target of $4.00. Ramakanth, who focuses on the Healthcare sector, has an average return of 22.5% and a 45.11% success rate on recommended stocks. Additionally, Quantum-Si received a Buy from Alliance Global Partners’ Scott Henry, while TR | OpenAI maintained a Hold rating on November 6.</p>

Quantum-Si (QSI) Receives a Buy from H.C. Wainwright